Bank of New York Mellon’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
|
|||||
2024
Q1 | $176K | Sell |
|
|||||
2023
Q4 | $245K | Sell |
|
|||||
2023
Q3 | $354K | Sell |
|
|||||
2023
Q2 | $737K | Buy |
|
|||||
2023
Q1 | – | Sell |
|
|||||
2022
Q4 | $74.5K | Hold |
|
|||||
2022
Q3 | $52K | Hold |
|
|||||
2022
Q2 | $99K | Sell |
|
|||||
2022
Q1 | $387K | Buy |
|
|||||
2021
Q4 | $483K | Buy |
|
|||||
2021
Q3 | $437K | Buy |
|
|||||
2021
Q2 | $2.16M | Buy |
|
|||||
2021
Q1 | $237K | Sell |
|
|||||
2020
Q4 | $179K | Buy |
|
|||||
2020
Q3 | $95K | Hold |
|
|||||
2020
Q2 | $49K | Sell |
|
|||||
2020
Q1 | $61K | Sell |
|
|||||
2019
Q4 | $114K | Hold |
|
|||||
2019
Q3 | $128K | Hold |
|
|||||
2019
Q2 | $164K | Buy |
|
|||||
2019
Q1 | $71K | Sell |
|
|||||
2018
Q4 | $98K | Hold |
|
|||||
2018
Q3 | $149K | Sell |
|
|||||
2018
Q2 | $147K | Buy |
|
|||||
2018
Q1 | $43K | Sell |
|
|||||
2017
Q4 | $37K | Buy |
|
|||||
2017
Q3 | $64K | Hold |
|
|||||
2017
Q2 | $63K | Sell |
|
|||||
2017
Q1 | $98K | Buy |
|
|||||
2016
Q4 | $77K | Sell |
|
|||||
2016
Q3 | $113K | Sell |
|
|||||
2016
Q2 | $112K | Buy |
|
|||||
2016
Q1 | $19K | Sell |
|
|||||
2015
Q4 | $241K | Buy |
|
|||||
2015
Q3 | $144K | Buy |
|
|||||
2015
Q2 | $111K | Sell |
|
|||||
2015
Q1 | $468K | Buy |
|
|||||
2014
Q4 | $585K | Sell |
|
|||||
2014
Q3 | $552K | Hold |
|
|||||
2014
Q2 | $654K | Buy |
|
|||||
2014
Q1 | $167K | Buy |
|